The anticancer compound JTE-607 reveals hidden sequence specificity of the mRNA 3′ processing machinery
Liang Liu(Hamamatsu University School of Medicine), Yongsheng Shi(Nanfang Hospital), Zhaoxia Yu(University of California, Irvine), Xueyi Teng(University of California, Irvine), Georg Seelig(University of Washington), Kristianna S.K. Sarkan(University of California, Irvine), Marielle Cárdenas Valdez(University of California, Irvine), Whitney England(University of California, Irvine), Lindsey V. Soles(University of California, Irvine), Angela M Yu(University of Washington), Ivan Marazzi(Icahn School of Medicine at Mount Sinai), Robert C. Spitale(University of California, Irvine), Xiuye Wang(University of California, Irvine), Yoseop Yoon(University of California, Irvine), Wei Li(Harbin Medical University), Feng Qiao(Anhui Medical University), Yi-Ling Chen(University of California, Irvine), Johannes Linder(Enzo Life Sciences (United States))
Cited by 14
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
|Molecular Cell|2020|207
Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation
|Nature Genetics|2025|163